Editions Ecce Terra CAMPARIS electron GFP microprobe facility Microscopie Confocale

Laboratoire de Microsondes Chromogenic in situ hybridization (CISH) – Microscope Electronique à Balayage

fallback-image

Ruxolitinib Invivogen

Human Anti centriole and centrosome antibody IgG ELISA kit

E01A0698-192T 192 tests
EUR 1524
Description: A competitive ELISA for quantitative measurement of Human Anti centriole and centrosome antibody IgG in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Human IgG antibody Laboratories manufactures the ruxolitinib invivogen reagents distributed by Genprice. The Ruxolitinib Invivogen reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact InVivoGen. Other Ruxolitinib products are available in stock. Specificity: Ruxolitinib Category: Invivogen

Human True insulin ELISA kit

1 plate of 96 wells
EUR 822
Description: A competitive ELISA for quantitative measurement of Human True insulin in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species.

Human True Insulin GENLISA ELISA

1 x 96 wells
EUR 286

Human True insulin ELISA kit

96T
EUR 700
Description: ELISA

True north Cryobox 0.2mLNatural

PK10
EUR 172.8

True north Cryobox 0.5mLNatural

PK10
EUR 153.6

True north Cryobox1.5/2mLNatural

PK10
EUR 100.8

True north Cryobox 5mLNatural

PK10
EUR 153.6

Chemicals information

Ruxolitinib phosphate

T3043-1mg 1mg Ask for price
Description: Ruxolitinib phosphate

Ruxolitinib phosphate

T3043-50mg 50mg Ask for price
Description: Ruxolitinib phosphate

Ruxolitinib phosphate

T3043-5mg 5mg Ask for price
Description: Ruxolitinib phosphate

Ruxolitinib phosphate

120209 10.0mg
EUR 90

EZSolution? Ruxolitinib

B2477-5 each
EUR 261.6

Ruxolitinib (INCB018424)

A3012-100 100 mg
EUR 448.8
Description: Ruxolitinib dihydrochloride is a specific inhibitor of Janus-associated kinase (JAK1 and JAK2). Ruxolitinib is a small molecular with the formula of C17H21N6O4Pand Molecular Weight of 404.

Ruxolitinib (INCB018424)

A3012-25 25 mg
EUR 268.8
Description: Ruxolitinib dihydrochloride is a specific inhibitor of Janus-associated kinase (JAK1 and JAK2). Ruxolitinib is a small molecular with the formula of C17H21N6O4Pand Molecular Weight of 404.

Ruxolitinib (INCB018424)

A3012-5 5 mg
EUR 157.2
Description: Ruxolitinib dihydrochloride is a specific inhibitor of Janus-associated kinase (JAK1 and JAK2). Ruxolitinib is a small molecular with the formula of C17H21N6O4Pand Molecular Weight of 404.

Ruxolitinib (INCB018424)

A3012-5.1 10 mM (in 1mL DMSO)
EUR 157.2
Description: Ruxolitinib dihydrochloride is a specific inhibitor of Janus-associated kinase (JAK1 and JAK2). Ruxolitinib is a small molecular with the formula of C17H21N6O4Pand Molecular Weight of 404.

Ruxolitinib (INCB018424)

A3012-S Evaluation Sample
EUR 97.2
Description: Ruxolitinib dihydrochloride is a specific inhibitor of Janus-associated kinase (JAK1 and JAK2). Ruxolitinib is a small molecular with the formula of C17H21N6O4Pand Molecular Weight of 404.

INCB018424 (Ruxolitinib)

E1KS1378 5mg
EUR 625.2

Ruxolitinib (free base)

10-042 25 mg
EUR 418.2
Description: Antineoplastic, anti-inflammatory and immunomodulating agent. Orally bioavailable potent ATP mimetic that inhibits both JAK1 and JAK2 with IC50 values of 2.7 and 4.5nM, respectively and is less selective for JAK3 (IC50=322nM). Affects DC differentiation and function, leading to impaired T cell activation. Used in the treatment of myeloproliferative neoplasms and psoriasis. Anticancer agent. Shown to induce apoptosis and autophagy. Potent and selective inhibitor of HIV-1 replication and virus reactivation in vitro. It is investigated against the spread of the SARS-CoV-2 (COVID-19).

Ruxolitinib, Free base

2139-100 each Ask for price

Ruxolitinib, Free base

2139-25 each
EUR 639.6

Ruxolitinib, Free base

2139-5 each
EUR 248.4

Ruxolitinib (free base)

GW2265-100 100
EUR 404.9

Ruxolitinib (free base)

GW2265-25 25
EUR 216.3

Articles récents

février 2024
L M M J V S D
 1234
567891011
12131415161718
19202122232425
26272829  

Catégories

Étiquettes